Rxo (RXO) Shares Outstanding (2022 - 2026)

Rxo (RXO) has 5 years of Shares Outstanding data on file, last reported at $164.9 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 0.58% year-over-year to $164.9 million; the trailing twelve-month figure through Mar 2026 stood at $164.9 million (up 0.58% YoY), and the FY2025 full-year result was $164.2 million, up 1.01% from the prior year.
• Shares Outstanding for Q1 2026 stood at $164.9 million, roughly flat from $164.2 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $164.9 million in Q1 2026 and bottomed at $116.4 million in Q4 2022.
• The 5-year median for Shares Outstanding is $139.2 million (2024), against an average of $140.3 million.
• The widest annual swing landed in 2023, when Shares Outstanding gained 0.54%; it then soared 39.45% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $116.4 million in 2022, then gained by 0.54% to $117.0 million in 2023, then surged by 38.87% to $162.5 million in 2024, then gained by 1.01% to $164.2 million in 2025, then grew by 0.43% to $164.9 million in 2026.
• The last three Shares Outstanding figures came in at $164.9 million (Q1 2026), $164.2 million (Q4 2025), and $164.1 million (Q3 2025), per Business Quant data.

Peer Comparison